MRSA

Top Story

Evidence-based care reduces mortality among patients with S. aureus bacteremia

Infectious Disease News, October 2017

Increasing the use of evidence-based care processes — such as appropriate antibiotic therapy, echocardiography and infectious disease consultation — in routine health care settings may improve survival for patients with Staphylococcus aureus bacteremia, according to findings published in JAMA Internal Medicine.

Staphylococcus aureus bacteremia is common and frequently associated with poor outcomes,” Michihiko Goto, MD, MSCI, a clinical assistant professor of internal medicine and hospital epidemiologist at the University of Iowa Carver College of Medicine, and colleagues wrote. “Evidence indicates that specific care processes are associated with improved outcomes for patients with S. aureus bacteremia, including appropriate antibiotic prescribing, use of echocardiography to identify endocarditis, and consultation with infectious diseases specialists. Whether use of these care processes has increased in routine care for S. aureus bacteremia or whether use of these processes has led to large-scale improvements in survival is unknown.”

Meeting News

Chlorhexidine reduces MRSA, VRE in patients with devices

October 7, 2017
SAN DIEGO — Daily universal bathing with chlorhexidine reduces the combination of MRSA and vancomycin-resistant enterococci in non-ICU hospital patients with…
Meeting News

MRSA recolonization linked to home contamination

October 5, 2017
SAN DIEGO — Patients who recovered from a community-acquired MRSA infection were four times more likely to be recolonized if their homes were contaminated with…
In the Journals Plus

MRSA, VRE present in hospital food, more studies on infection needed

October 4, 2017
MRSA and vancomycin-resistant Enterococci can be present in hospital food, although patient infection with either may be uncommon, according to researchers. The mere…
More Headlines »
CME CNE CPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
More »
Editorial

Funding for medical research and public health must reflect reality

Infectious Disease News, July 2017
William Powderly, MD
The last few years have seen a growing force of infectious disease challenges that together pose an unprecedented range…
More »
Resource Centers
IDWeek

IDWeek

Video
Meeting News Coverage

VIDEO: Experts focus on vaccines to combat antimicrobial resistance

April 26, 2016
More »
Advertisement
Advertisement